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We have invcsligjated the effect or proteas¢ activity on cyclic AMP production and steroidogenesls in rat testis mouse testis and mouse turnout 
i.,¢ydil! (MAIOI cells. L[-I-, dibut~tr~tl cyclic AMP., and forskolin-stimulated steroidogenesis, but not 22R(OH) cholesterol conversion to preimeno- 
lone, was Inhibited by proteaso lnhibitors. In mouse l~ydi$ cells, LH but not forskolin or cholera toxin stimulated cyclic AMP production was 
inhibited by proteas¢ lnhibitors. These results ugi]est hat sleroidogenesis in Leydig ceils requires proteolysis before the conversion or cholesterol 
to prcilncnolone, in th, mouse bus not rat Leydig cells, LH.stimulated cyclic AMP production is also del~ndent on proteolysis, 
Luteinizing hormone: Steroidogencfis; Cyclic, AMP; Proteolysis 
1, INTRODUCTION 
Luteinizing hormone (LH) interacts with a specific 
cell surface receptor to stimulate steroidogenesis in 
Leydig cells. The hormonally regulated, rate limiting 
steps in steroid formation is thought to be tl~e transport 
of cholesterol [1], A possible protein candidate for this 
role was isolated from a Leydig cell tumor; the 
'steroidogenesis activator polypeptide' (SAP) [2] was 
proposed to be cleaved from a glucose-regulated pro- 
tein (GRP78) by a regulated process that is related to 
steroidogenesis [3], indicating the possible involvement 
of protease activity in steroidogenesis. Previously we 
have shown that inhibition of protease activity 
prevented the loss of receptors during down-regulation 
in MAIO cells and caused a 2-3-fold increase in LH 
receptor numbers in rat Leydig cells, with a similar in- 
crease in cyclic AMP production [4]. We have therefore 
investigated the effect of inhibiting protease activity in 
Leydig cells on the subsequent s imulated cyclic AMP 
production and steroidogenesis. 
2. MATERIALS AND METHODS 
Stock cultures of MAI0 cells were maintained in Waymouth's 
MB752/1 medium according to the method of Ascoli (1981) [5]. Adult 
male Sprague-Dawley rat Leydig cells were prepared by collagenase 
dispersion, centrifugal elutriation and Percoll density gradient cen- 
trifugation and incubated as previously described [6] in DMEM 
(Gibco)-0.1°]0 BSA (bovine serum albumin, Sigma). Adult male 
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BALB/C mice Leydig ceils were prepared lay mechanical dispersion 
using a 50 ml syringe, followed by Percoll density gradient ¢entrifuga- 
tlon [7] and incubated as for the rat Leydtg cells, i,.eydig cell purity 
was established by 31~-hydroxysteroid dehydrogenasc cytochemistry 
[8], 
The addition of cyanoketone (5 t~M) and SU-10603 (20 uM) 
(pregnenolone metabolism inl~ibitors) (Sterling Research Lid.) and 
protease inhibitors was made 30 rain prior to the addition of other 
reagents, The latter inhibitors (leupeptin (100 taM), PMSF (10/~M) 
and aprotinin (900 units/rot) (Sigma) were added as 100.fold coneen. 
trated alictuots to the incubation medium. LH (NIA.MDD.oLH.22, 
2.3 IU/mg, Bethesda, MD, USA), dibutyryl cyclic AMP, forskolin 
and cl~olera toxin (Sigma) were dissolved in incubation medium and 
22R(OH) cholesterol and pregnenolone (Sigma) were dissolved in 
DMSO Incubations were stopped with HCIO~ and stored frozen at 
-20°C. Samples were thawed and neutralized with K3PO+ prior to 
radioimmunoassay of testosterone [9], pregnenolone [10] and cyclic 
AMP [11,12]. Statistical analysis was by the Student's t.test. 
3. RESULTS 
MAI0 and rat Leydig cells were preincubated for 30 
min with [eupeptin (100 /zM), PMSF (10 tiM), and 
aprotinin (900 units/ml) in 1 ml of media at 34°C. LH 
(0.033 nM and 0.33 aM), 22R(OH)-cholesterol (5/~M), 
cholera toxin (1.19 nM), forskolin (8 #M) or dibutyryl 
cyclic AMP (1 raM) were then added for 2 h. The reac- 
tions were stopped and measured for pregnenolone, 
testosterone and cyclic AMP production. Fig. 1 shows 
the effect of the protease inhibitors on pregnenolone 
production in rat Leydig (Fig. IA) and MAIO (Fig. 1B) 
cells. LH, forskolin and dibutyryl cyclic AMP 
stimulated pregnenolone were all inhibited in both cell 
types. There was no effect on the conversion of 
22R(OH)-cholesterol t  pregnenolone. Fig. 2 shows the 
effect of protease inhibitors on testosterone production 
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Fig. 1. The effect of pretense inhibitors on pregnenolone production 
in Leydig cells. Rat Leydig (A) and MAI0 (B) cells were plated at 
10~/well with 1 ml incubation medium, The cells were preincubated 
for 30 min with or without pretense inhibitors before the addition of 
reagents. Pretense inhibitors were present hrough the incubations, 
Cells were incubaled for 2 h in the absence (~)  or presence of 0,033 
nM (k~), 0,33 nM (~)LH,  5 #M (~)22R(OH)cholesterol, 1 mM ((~1) 
dibutyryl cyclic AMP or 8 wM (E~) forskolin. Data represent the mean 
± SD of 2 experiments. Significant differences are shown for inhition 
only (*P<0,001), 
in rat Leydig cells. In these experiments LH, dibutyryl 
cyclic AMP, and forskolin stimulated testosterone were 
inhibited. Pregnenolone and 22R(OH)-cholesterol con- 
version to testosterone were inhibited but to a lesser ex- 
tent. 
Previously we have shown that LH-stimulated, but 
not cholera toxin- or forskolin-stimulated, cyclic AMP 
production in the rat Leydig cells was increased by two- 
to three-fold in the presence of protease inhibitors [4]. 
Fig. 3 shows cyclic AMP production in MAI0 cells in 
the absence and presence of pretense inhibitors. Both 
0.33 nM and 3.3 nM LH-stimulated cyclic AMP pro- 
duction was inhibited by 70°70, but forskolin- and 
cholera toxin-stimulated cyclic AMP production was 
unaffected. 
As the difference in the effect of pretense inhibitors 
on cyclic AMP production between the MA10 cell and 
the normal rat testis Leydig cell, may have been a result 
of  the MAI0 cell being a tumour cell, we repeated our 
studies on normal mouse testis Leydig cells. The follow- 
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Fig. 2, The ©fr©ct of protease tnhibhors on testosterone production in 
rat testis Leydlll cells. Ceil~ were plated at 10~/well with 1 ntl Inc~,lba. 
lion medium, The cells were preincubnted for 30 mln with or without 
pro~ease inhtbhors before the addition or reagents, Protease in. 
hibitors were present hrough the incubations. Cells were incubated 
for 2 h in the absence (~) or presence oro,033 nM ([~), 0.33 nM (~)  
LH, $/=M (R)) presnenolone, $ ~tM (F~) 22R(OH] cholesterol, 8 ~=M 
(~)  forskolln or 1 mM (~)  dibutyryl cyclic AMP. Data represent he 
mean ± SD of 2. experiments, Sitniricant differences are shown [or 
inhibition only (*P<0,05, *'P<0.001). 
ing results which are the mean ± SD of 3 replicates 
were obtained, LH-stimulated cyclic AMP production 
was inhibited from 205.8 ± 58 to 21.2 ± 5.7 pmol/106 
cells/2 h. Stimulation of cyclic AMP by forskolin was 
unaffected (untreated; 132.0± 1.1 pmol/106 cells/2 h : 
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Fig. 3. The effect of pretense inhibitors on cyclic AMP production in 
MA10 cells. Cells were plated at 105/well with 1 ml incubation 
medium. The cells were preincubated for 30 rain with or without pro- 
tease inhibitors before the addition of reagents, Pretense inhibitors 
were present hrough the incubations. Cells were incubated for 2 h in 
the absence ([]) or presence of 0.033 nM ([]), 0.33 nM (~)  LH, 8/~M 
(~1 forskolin or 1.19 nM (E~) cholera toxin. Data represent the mean 
± SD of 2 experiments. Significant differences are shown for inhibi- 
tion only (*P<0.001), 
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proteas~, inhibitor-treated; 124±9.3 pmol l l0  ~ cellsl2 
h}. LH.st imulated (71I :~ 32 n~l/10 ~ cells/2 h) and db- 
cAMP-stimulated ¢759±88 ngt l0  n c~'llst2 h} 
testosterone production was also inhibited in tl~e 
presence of the pretense inhibitors (LH;  259:t: 146 
ng/10 a cells/2 h : db-cAMP; 279 ± ~2 ng/10 ~ cells!2 h), 
There  was partial Inhibition of  22R(OH)-cholesterol 
conversion to testosterone (1019 ~ 10 to 748 ± I 1 ng/ l  0 ~ 
cel ls/2 h}. This is  similar to the results for 22R(OH)- 
cholesterol conversion to test osterone in rat Leydtg cells 
(Fig. 2). 
4. DISCUSSION 
The present experiments indicate that serine pro- 
teases are involved in the control of  steroidogenesis in 
mouse and rat Leydig ceils at a step after cyclic AMP 
product ion and before side.chain cleavage of 
cholesterol, In addition, in the mouse Leydig cells, pro- 
teases are required for the stimulation of  cyclic AMP 
production by LH, 
The evidence for the location of  the action of  the pro, 
teases on steroidogenesis is based on the fotmd inhibi- 
tion of  both LH-  and db-cAMP-st imulated testosterone 
product ion and the lack of effect on 22R(OH)- 
cholesterol conversion to pregnenolone. It is recognized 
that the rate-limiting step in steroidogenesis the 
transport  o f  cholesterol f rom the outer to the inner 
mitochondrial  membrane and that a earner protein is 
required for this transport [1]. 22R(OH)-Cholesterol 
bypasses this rate-limiting step and has direct access to 
the inner mitochondrial membrane where it undergoes 
side-chain cleavage, It has also been shown that 
cholesterol stored in the plasma membrane is utilized 
for mitochondrial  steroidogenesis [12] and that cyclic 
AMP regulates its transport in MA10 cells. Our ex- 
periments indicate, therefore, that the transport of 
cholesterol f rom either the plasma membrane and/or  
f rom the outer to inner mitochondrial  membrane may 
require the proteolysis o f  a cholesterol carrier precursor 
protein. 
The inhibition of LH-st imulated cyclic AMP produc- 
tion by pretense inhibitors in the MA10 and normal 
mouse Leydig cells is in contrast o the results obtained 
for the rat, where a 2-3-fold increase in cyclic AMP was 
observed [3] under the same conditions. As no effect of 
the protease inhibitors is seen on forskolin- or cholera 
toxin-stimulated cyclic AMP,  the protease inhibitors 
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most probably modulate the LH receptor. This may in- 
dicate that in mouse Leydlg cells proteolysis of  the LH 
receptor is required for activation or that the inhibitors 
arc affecting the binding of LH.  The latter is unlikely 
however, because pretense inhibitors have no effect on 
the binding characteristics or  [==~I]hCG [3]. We have 
previously demonstrated that pretenses have a direct ef- 
fect on the LH receptor by causing truncation of  its ex- 
tracellular domain,  and that truncation is regulated by 
an inhibition of  internalization of the receptor in the 
mouse but not the rat [3], Further studies are required 
to determine if  there is a relationship between trunca- 
tion and activation of  adenylat¢ cyclase in the mouse 
Leydig cell. 
To conclude, tile present report and our previous 
studies indicate that proteases have an important role in 
tl~e regulation of  steroidogenesis via mo-lulation of the 
LH receptor, causing both truncation and activation of 
adenylat¢ cyclase, and by regulating cholesterol 
transport. 
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